Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.

Polysaccharide-encapsulated organisms are the leading cause of bacterial meningitis and pneumonia in children. The use of protein-polysaccharide conjugate vaccines in developed countries over the past two decades has markedly decreased the burden of disease and mortality from these organisms through...

Full description

Bibliographic Details
Main Authors: Pollard, A, Perrett, K, Beverley, P
Format: Journal article
Language:English
Published: 2009
_version_ 1826270124898779136
author Pollard, A
Perrett, K
Beverley, P
author_facet Pollard, A
Perrett, K
Beverley, P
author_sort Pollard, A
collection OXFORD
description Polysaccharide-encapsulated organisms are the leading cause of bacterial meningitis and pneumonia in children. The use of protein-polysaccharide conjugate vaccines in developed countries over the past two decades has markedly decreased the burden of disease and mortality from these organisms through direct protection of the immunized and through herd immunity. In the next decade, the widespread use of conjugate vaccines in the developing world should prevent millions of deaths. In this Science and Society article, we describe how vaccine-induced immunity wanes rapidly after vaccination in early childhood and argue that strategies that sustain protection in the population must be considered.
first_indexed 2024-03-06T21:35:56Z
format Journal article
id oxford-uuid:46461ebf-2199-4229-b49f-9d2a419990ce
institution University of Oxford
language English
last_indexed 2024-03-06T21:35:56Z
publishDate 2009
record_format dspace
spelling oxford-uuid:46461ebf-2199-4229-b49f-9d2a419990ce2022-03-26T15:12:44ZMaintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:46461ebf-2199-4229-b49f-9d2a419990ceEnglishSymplectic Elements at Oxford2009Pollard, APerrett, KBeverley, PPolysaccharide-encapsulated organisms are the leading cause of bacterial meningitis and pneumonia in children. The use of protein-polysaccharide conjugate vaccines in developed countries over the past two decades has markedly decreased the burden of disease and mortality from these organisms through direct protection of the immunized and through herd immunity. In the next decade, the widespread use of conjugate vaccines in the developing world should prevent millions of deaths. In this Science and Society article, we describe how vaccine-induced immunity wanes rapidly after vaccination in early childhood and argue that strategies that sustain protection in the population must be considered.
spellingShingle Pollard, A
Perrett, K
Beverley, P
Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.
title Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.
title_full Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.
title_fullStr Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.
title_full_unstemmed Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.
title_short Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.
title_sort maintaining protection against invasive bacteria with protein polysaccharide conjugate vaccines
work_keys_str_mv AT pollarda maintainingprotectionagainstinvasivebacteriawithproteinpolysaccharideconjugatevaccines
AT perrettk maintainingprotectionagainstinvasivebacteriawithproteinpolysaccharideconjugatevaccines
AT beverleyp maintainingprotectionagainstinvasivebacteriawithproteinpolysaccharideconjugatevaccines